<p>随着美国股市表现参差不齐，道琼斯指数和标准普尔 500 指数出现上涨，而以科技为主的行业面临挑战，投资者正在探索多样化的机会。虽然 “便士股票” 这一术语在投资中较为陈旧，但它仍然代表了一部分较小或不太成熟的公司，这些公司可能提供显著的价值。通过关注那些财务健康且具有增长潜力的公司，投资者可以在这些鲜为人知的股票中发现有前景的机会。</p>
<h3>美国十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$1.75</td>
<td>$379.32M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.815</td>
<td>$658.23M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.745</td>
<td>$588.08M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.95</td>
<td>$1.2B</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Puma Biotechnology (PBYI)</td>
<td>$4.97</td>
<td>$246.41M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Performance Shipping (PSHG)</td>
<td>$2.2293</td>
<td>$27.72M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.47</td>
<td>$568.6M</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.93</td>
<td>$51.75M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.80</td>
<td>$6.53M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.775</td>
<td>$85.41M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国便士股票筛选器的 357 只股票的完整列表。</p>
<p>我们将查看筛选工具中一些最佳选择。</p>
<h2>Alpha Teknova (TKNO)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Alpha Teknova, Inc. 生产用于全球新疗法、疫苗和分子诊断发现、开发和商业化的基本试剂，市值为 2.3018 亿美元。</p>
<p><strong>运营：</strong> 公司的收入来自其特种化学品部门，该部门产生了 3980 万美元的收入。</p>
<p><strong>市值：</strong> $230.18M</p>
<p>Alpha Teknova, Inc. 在便士股票市场中航行，市值为 2.3018 亿美元，收入主要来自其特种化学品部门，总计 3980 万美元。该公司保持强劲的现金状况，覆盖短期和长期负债，同时积极寻求收购以增强增长和盈利前景。尽管过去五年亏损不断增加，但 Teknova 最近的财报显示净亏损数字较去年有所改善。预计收入将以每年 14.25% 的速度增长，尽管相对于大多数美国股票，波动性仍然较高。</p>
<ul>
<li>在我们的财务健康报告中更详细地了解 Alpha Teknova 的潜力。</li>
<li>通过访问我们的收益增长报告评估 Alpha Teknova 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis"/></p>
<p>TKNO 财务状况分析截至 2025 年 11 月</p>
<h2>Marqeta (MQ)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Marqeta, Inc. 运营一个基于云的开放 API 平台，提供卡片发行和交易处理服务，市值约为 20.9 亿美元。</p>
<p><strong>运营：</strong> 公司的收入来自其数据处理部门，该部门产生了 5.8856 亿美元的收入。</p>
<p><strong>市值：</strong> $2.09B</p>
<p>Marqeta, Inc. 市值为 20.9 亿美元，通过利用其基于云的 API 平台进行卡片发行和交易处理，正在便士股票市场中航行。尽管处于亏损状态，Marqeta 在五年内减少了亏损，并保持超过三年的良好现金流。该公司最近报告的第三季度销售额为 1.6331 亿美元，净亏损显著低于去年。与 Klarna 的卡片扩展到 15 个欧洲市场等合作，突显了 Marqeta 的战略合作伙伴关系和收入增长潜力，预计在 2025 年第四季度增长 22% 至 24%。</p>
<ul>
<li>点击这里发现 Marqeta 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>在这里了解 Marqeta 未来的增长轨迹。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis"/></p>
<p>MQ 财务状况分析截至 2025 年 11 月</p>
<h2>Hyliion Holdings (HYLN)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Hyliion Holdings Corp. 设计和开发用于静态和移动应用的发电机，市值约为 2.9916 亿美元。</p>
<p><strong>运营：</strong> Hyliion Holdings Corp. 尚未报告任何具体的收入部门。</p>
<p><strong>市值：</strong> $299.16M</p>
<p>Hyliion Holdings，市值为 2.9916 亿美元，是一家专注于创新电力解决方案的无收入公司。尽管处于亏损状态，并在 2025 年前九个月报告了 4401 万美元的净亏损，但它没有债务，并保持超过一年的现金流。最近成功的 KARNO 电源模块排放测试使 Hyliion 在清洁能源技术的前沿，可能增强其在各个行业的商业前景。然而，其高股价波动性和缺乏有意义的收入突显了投资于此类早期阶段企业的固有风险。</p>
<ul>
<li>在这里通过我们的综合资产负债表健康报告深入了解 Hyliion Holdings。</li>
<li>检查 Hyliion Holdings 的收益增长报告，以了解分析师对其表现的预期。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis"/></p>
<p>HYLN 财务状况分析截至 2025 年 11 月</p>
<h2>下一步</h2>
<ul>
<li>通过使用我们的筛选器，深入了解所有 357 只美国便士股票。</li>
<li>想探索一些替代方案吗？我们发现 14 只预计明年将支付超过 6% 股息收益率的美国股票。查看完整列表，免费获取。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章不应被视为财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

HYLN

TKNO

<p>这篇文章强调了在美国股市波动中，便士股票的潜力，重点关注了 Alpha Teknova、Marqeta 和 Hyliion Holdings。Alpha Teknova 市值为 2.3018 亿美元，以其强劲的现金状况和预期的收入增长而受到关注。Marqeta 的估值为 20.9 亿美元，利用其基于云的 API 平台实现增长，而 Hyliion Holdings 市值为 2.9916 亿美元，尽管面临高波动性和缺乏收入，仍专注于清洁能源技术。文章强调了与这些股票相关的机会和风险</p>

<p>As the U.S. stock market experiences a mixed performance with major indices like the Dow Jones and S&amp;P 500 showing gains, while tech-heavy sectors face challenges, investors are exploring diverse opportunities. Penny stocks, though an older term in investing, continue to represent a segment of smaller or less-established companies that can offer significant value. By focusing on those with strong financial health and potential for growth, investors can discover promising opportunities among these lesser-known stocks.</p>
<div class="lb-trans"><p>随着美国股市表现参差不齐，道琼斯指数和标准普尔 500 指数出现上涨，而以科技为主的行业面临挑战，投资者正在探索多样化的机会。虽然 “便士股票” 这一术语在投资中较为陈旧，但它仍然代表了一部分较小或不太成熟的公司，这些公司可能提供显著的价值。通过关注那些财务健康且具有增长潜力的公司，投资者可以在这些鲜为人知的股票中发现有前景的机会。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美国十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$1.75</td>
<td>$379.32M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.815</td>
<td>$658.23M</td>
<td>✅ 4 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.745</td>
<td>$588.08M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.95</td>
<td>$1.2B</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Puma Biotechnology (PBYI)</td>
<td>$4.97</td>
<td>$246.41M</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Performance Shipping (PSHG)</td>
<td>$2.2293</td>
<td>$27.72M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.47</td>
<td>$568.6M</td>
<td>✅ 5 ⚠️ 0 View Analysis &gt;</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.93</td>
<td>$51.75M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.80</td>
<td>$6.53M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.775</td>
<td>$85.41M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Dingdong (Cayman) (DDL)</td>
<td>$1.75</td>
<td>$379.32M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Waterdrop (WDH)</td>
<td>$1.815</td>
<td>$658.23M</td>
<td>✅ 4 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>LexinFintech Holdings (LX)</td>
<td>$3.745</td>
<td>$588.08M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>FinVolution Group (FINV)</td>
<td>$4.95</td>
<td>$1.2B</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Puma Biotechnology (PBYI)</td>
<td>$4.97</td>
<td>$246.41M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Performance Shipping (PSHG)</td>
<td>$2.2293</td>
<td>$27.72M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CI&amp;T (CINT)</td>
<td>$4.47</td>
<td>$568.6M</td>
<td>✅ 5 ⚠️ 0 查看分析</td>
</tr>
<tr>
<td>Nephros (NEPH)</td>
<td>$4.93</td>
<td>$51.75M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>BAB (BABB)</td>
<td>$0.80</td>
<td>$6.53M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (LCUT)</td>
<td>$3.775</td>
<td>$85.41M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 357 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国便士股票筛选器的 357 只股票的完整列表。</p>
</div><p>We're going to check out a few of the best picks from our screener tool.</p>
<div class="lb-trans"><p>我们将查看筛选工具中一些最佳选择。</p>
</div><h2>Alpha Teknova (TKNO)</h2>
<div class="lb-trans"><h2>Alpha Teknova (TKNO)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Alpha Teknova, Inc. produces essential reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics globally with a market cap of $230.18 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Alpha Teknova, Inc. 生产用于全球新疗法、疫苗和分子诊断发现、开发和商业化的基本试剂，市值为 2.3018 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from its Specialty Chemicals segment, which generated $39.80 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自其特种化学品部门，该部门产生了 3980 万美元的收入。</p>
</div><p><strong>Market Cap:</strong> $230.18M</p>
<div class="lb-trans"><p><strong>市值：</strong> $230.18M</p>
</div><p>Alpha Teknova, Inc. is navigating the penny stock landscape with a market cap of US$230.18 million and revenue primarily from its Specialty Chemicals segment, totaling US$39.80 million. The company maintains a strong cash position, covering both short and long-term liabilities, while actively seeking acquisitions to enhance growth and profitability prospects. Despite being unprofitable with increasing losses over the past five years, Teknova's recent earnings report showed improved net loss figures compared to the previous year. Revenue is projected to grow 14.25% annually, though volatility remains high relative to most U.S. stocks.</p>
<div class="lb-trans"><p>Alpha Teknova, Inc. 在便士股票市场中航行，市值为 2.3018 亿美元，收入主要来自其特种化学品部门，总计 3980 万美元。该公司保持强劲的现金状况，覆盖短期和长期负债，同时积极寻求收购以增强增长和盈利前景。尽管过去五年亏损不断增加，但 Teknova 最近的财报显示净亏损数字较去年有所改善。预计收入将以每年 14.25% 的速度增长，尽管相对于大多数美国股票，波动性仍然较高。</p>
</div><ul>
<li>Take a closer look at Alpha Teknova's potential here in our financial health report.</li>
<li>Evaluate Alpha Teknova's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的财务健康报告中更详细地了解 Alpha Teknova 的潜力。</li>
<li>通过访问我们的收益增长报告评估 Alpha Teknova 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/a412f7f5-9a07-448c-9614-8a7f33380346/chart/financial-position-analysis"/></p>
<p>TKNO Financial Position Analysis as at Nov 2025</p>
<div class="lb-trans"><p>TKNO 财务状况分析截至 2025 年 11 月</p>
</div><h2>Marqeta (MQ)</h2>
<div class="lb-trans"><h2>Marqeta (MQ)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Marqeta, Inc. operates a cloud-based open API platform for card issuing and transaction processing services, with a market cap of approximately $2.09 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Marqeta, Inc. 运营一个基于云的开放 API 平台，提供卡片发行和交易处理服务，市值约为 20.9 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from its data processing segment, which generated $588.56 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自其数据处理部门，该部门产生了 5.8856 亿美元的收入。</p>
</div><p><strong>Market Cap:</strong> $2.09B</p>
<div class="lb-trans"><p><strong>市值：</strong> $2.09B</p>
</div><p>Marqeta, Inc., with a market cap of US$2.09 billion, is navigating the penny stock landscape by leveraging its cloud-based API platform for card issuing and transaction processing. Despite being unprofitable, Marqeta has reduced losses over five years and maintains a solid cash runway exceeding three years due to positive free cash flow. The company recently reported third-quarter sales of US$163.31 million with a net loss significantly reduced from the previous year. Collaborations like the expansion of Klarna's card into 15 European markets highlight Marqeta's strategic partnerships and potential for revenue growth, projected at 22% to 24% in Q4 2025.</p>
<div class="lb-trans"><p>Marqeta, Inc. 市值为 20.9 亿美元，通过利用其基于云的 API 平台进行卡片发行和交易处理，正在便士股票市场中航行。尽管处于亏损状态，Marqeta 在五年内减少了亏损，并保持超过三年的良好现金流。该公司最近报告的第三季度销售额为 1.6331 亿美元，净亏损显著低于去年。与 Klarna 的卡片扩展到 15 个欧洲市场等合作，突显了 Marqeta 的战略合作伙伴关系和收入增长潜力，预计在 2025 年第四季度增长 22% 至 24%。</p>
</div><ul>
<li>Click here to discover the nuances of Marqeta with our detailed analytical financial health report.</li>
<li>Learn about Marqeta's future growth trajectory here.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里发现 Marqeta 的细微差别，查看我们的详细分析财务健康报告。</li>
<li>在这里了解 Marqeta 未来的增长轨迹。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/992c8690-3ba6-4d48-a98a-f1ceb1d35f42/chart/financial-position-analysis"/></p>
<p>MQ Financial Position Analysis as at Nov 2025</p>
<div class="lb-trans"><p>MQ 财务状况分析截至 2025 年 11 月</p>
</div><h2>Hyliion Holdings (HYLN)</h2>
<div class="lb-trans"><h2>Hyliion Holdings (HYLN)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Hyliion Holdings Corp. designs and develops power generators for stationary and mobile applications, with a market cap of approximately $299.16 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Hyliion Holdings Corp. 设计和开发用于静态和移动应用的发电机，市值约为 2.9916 亿美元。</p>
</div><p><strong>Operations:</strong> Hyliion Holdings Corp. has not reported any specific revenue segments.</p>
<div class="lb-trans"><p><strong>运营：</strong> Hyliion Holdings Corp. 尚未报告任何具体的收入部门。</p>
</div><p><strong>Market Cap:</strong> $299.16M</p>
<div class="lb-trans"><p><strong>市值：</strong> $299.16M</p>
</div><p>Hyliion Holdings, with a market cap of US$299.16 million, is a pre-revenue company focused on innovative power solutions. Despite being unprofitable and reporting a net loss of US$44.01 million for the first nine months of 2025, it has no debt and maintains sufficient cash runway for over a year. The recent successful emissions testing of its KARNO Power Module positions Hyliion at the forefront of clean energy technology, potentially enhancing its commercial prospects across various sectors. However, its high share price volatility and lack of meaningful revenue highlight the inherent risks associated with investing in such early-stage ventures.</p>
<div class="lb-trans"><p>Hyliion Holdings，市值为 2.9916 亿美元，是一家专注于创新电力解决方案的无收入公司。尽管处于亏损状态，并在 2025 年前九个月报告了 4401 万美元的净亏损，但它没有债务，并保持超过一年的现金流。最近成功的 KARNO 电源模块排放测试使 Hyliion 在清洁能源技术的前沿，可能增强其在各个行业的商业前景。然而，其高股价波动性和缺乏有意义的收入突显了投资于此类早期阶段企业的固有风险。</p>
</div><ul>
<li>Navigate through the intricacies of Hyliion Holdings with our comprehensive balance sheet health report here.</li>
<li>Examine Hyliion Holdings' earnings growth report to understand how analysts expect it to perform.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里通过我们的综合资产负债表健康报告深入了解 Hyliion Holdings。</li>
<li>检查 Hyliion Holdings 的收益增长报告，以了解分析师对其表现的预期。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/fb9f2855-7b62-462b-bcd7-cb901c7ca573/chart/financial-position-analysis"/></p>
<p>HYLN Financial Position Analysis as at Nov 2025</p>
<div class="lb-trans"><p>HYLN 财务状况分析截至 2025 年 11 月</p>
</div><h2>Next Steps</h2>
<div class="lb-trans"><h2>下一步</h2>
</div><ul>
<li>Get an in-depth perspective on all 357 US Penny Stocks by using our screener here.</li>
<li>Want To Explore Some Alternatives? We've found 14 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过使用我们的筛选器，深入了解所有 357 只美国便士股票。</li>
<li>想探索一些替代方案吗？我们发现 14 只预计明年将支付超过 6% 股息收益率的美国股票。查看完整列表，免费获取。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章不应被视为财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

Alpha Teknova 是值得关注的三只便士股票之一